Decrease in CD4+ T-cell counts in patients with multiple myeloma treated with bortezomib.
Related Research units
Abstract
Bortezomib is highly effective in multiple myeloma and is widely used in this disease. Recently, an increased incidence of varicella zoster virus (VZV) reactivation was reported in patients with myeloma undergoing bortezomib treatment.
Bibliographical data
| Original language | German |
|---|---|
| Article number | 2 |
| ISSN | 2152-2650 |
| Publication status | Published - 2010 |
| pubmed | 20371447 |
|---|
